Global Enzyme-linked Immunosorbent Assays (ELISAs) Market to Grow at a CAGR of 3.0% During the Period 2024-2032, Driven by Efficient Solutions by Leading Firms.

The global enzyme-linked immunosorbent assays (ELISAs) market is expected to be driven by applications of ELISAs in different settings. ELISAs are very sensitive and employed to detect and quantify substances, including antibodies, antigens, proteins, glycoproteins, and hormones. These have broad variety of applications, including clinical, forensic and food research. Enzyme-linked immunosorbent assay (ELISA) is also used to determine concentrations of illegal drugs, like cannabinoids, amphetamines, opiates, cocaine, benzodiazepines, and methadone, in urine samples. In the food industry, enzyme-linked immunosorbent assay (ELISA) is used to determine the presence of allergens for legally required ingredient labelling. Also, ELISAs are a less expensive and complicated method for detection of platelet antibodies. North America, Europe and Asia are likely to be key markets.

Leading firms are engaged in developing and offering novel solutions. For example, in 2020, Thermo Fisher Scientific expanded its COVID-19 tests portfolio with two new antibody tests – Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test, and the Thermo Scientific EliA SARS-CoV-2-Sp1 IgG test. OmniPATH COVID-19 Total Antibody ELISA Test was an enzyme-linked immunosorbent assay (ELISA) meant for qualitative detection of total antibodies (including immunoglobulin M (IgM), immunoglobulin A (IgA) and immunoglobulin G (IgG) to SARS-CoV-2 in human serum. The open ELISA platform detected antibodies to the receptor binding domain (RBD) of the S1 subunit of the spike (S) protein. Such solutions are expected to drive the global enzyme-linked immunosorbent assays (ELISAs) market. The assay offered hundred percent sensitivity and specificity in symptomatic patients - fifteen days post-symptom onset, as well as high sensitivity (83.1%) after eight days.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

BD Biosciences offers, among other solutions, BD immunoassay ELISA reagents that contain antibody pairs that have each been developed to work together to quantitate soluble analytes in serum, plasma and tissue culture supernatants using sandwich ELISA. The reagents are available in three convenient sandwich ELISA formats and offer flexibility and cost efficiency for the analysis of tissue culture supernatants. BD OptEIA™ Kits contain all essential reagents and precoated 96-well plates for analysis. BD OptEIA™ Sets include adequate capture/detection reagents and standards for five or twenty 96-well plates.

In 2020, BD (Becton, Dickinson and Company) and BioGX Inc., announced that the U.S. Food and Drug Administration (FDA) had granted Emergency Use Authorization (EUA) for a new diagnostic test that would enable hospitals to screen for COVID-19 (coronavirus) on site and get results in under three hours.

BioLegend offers ELISA kits and sets; the company offers all the reagents for ELISA workflow with economical kits, antibodies, and ancillary reagents. BioLegend provides four types of ELISA kits, including easy-to-use LEGEND MAX™ kits with pre-coated plates and RAPID MAX™ kits that reduce assay time down to ninety minutes. In addition, the company offers reliable antibody pairs, ancillary reagents, and standards for those who want to develop their own ELISA assays. Offerings include (among others): RAPID MAX™ ELISA Kits (cut assay time down to under ninety minutes; each kit is completely validated and carries a 96-well strip plate that is pre-coated to immobilize the capture antibody); LEGEND MAX™ ELISA Kits (fully validated and ready-to-use; contain all essential reagents, including a 96-well strip plate pre-coated with capture antibody); ELISA MAX™ Deluxe Sets (contain pre-optimized reagents and some additional buffers/solutions, while being a cost-effective alternative); and ELISA MAX™ Standard Sets (provide the basic components required to complete an ELISA).

Bio-Rad offers a comprehensive range of buffers and substrates for optimizing ELISAs. Offerings include Coating Buffers [ELISA Coating Buffer (BUF030), AbGuard® Plate Stabilizer (BUF063)], Blocking Buffers [Block Ace (BUF029), BSA Block (BUF032), Ultrablock (BUF033), Synblock (BUF034)], Assay Diluents [General Assay Diluent (BUF037), IgM Reducing Assay Diluent (BUF038), Neptune Assay Diluent (BUF039), HISPEC Assay Diluent (BUF049)], etc.

Key Findings of the Report:

• Applications in different settings are expected to drive the global enzyme-linked immunosorbent assays (ELISAs) market.

• Important applications for developing countries and efficient solutions being offered by leading firms are likely to boost market growth. 

• North America, Europe and Asia are projected to be key markets.

Market Analysis by Test Type, Application and Region:

• By test type, the market is segmented into Sandwich ELISA, Competitive ELISA, Indirect ELISA, Multiple and Portable ELISA, and Others.

• By application, the market is divided into Cancer, Protein Quantification, Immunology, Inflammation, Infectious Diseases, and Others.

• By region, the market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790